Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
Jorge A. Marrero(University of Pennsylvania), Riccardo Lencioni(University of Pisa), Robert Lehr(Bayer (United States)), Stephanie Heldner(Bayer (Germany)), Christos N. Papandreou(University Hospital of Larissa), Masatoshi Kudo(Kindai University), Alan P. Venook(University of California, San Francisco), Lucy Dagher(Policlinica Metropolitana), Seung Kew Yoon(The Catholic University of Korea Seoul St. Mary's Hospital), Junji Furuse(Kanagawa Prefectural Hospital Organization), Arun J. Sanyal(Virginia Commonwealth University), Xiao‐Ping Chen(University of Washington), Tadatoshi Takayama(Nihon University), Laura Ladrón de Guevara(Centro Medico Nacional Siglo XXI), Jean-François H. Geschwind(Johns Hopkins University), Sheng-Long Ye(Fudan University), Jean-Pierre Bronowicki(Université de Lorraine), Keiko Nakajima(Bayer (United States))
Cited by 385
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.1k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k